Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
12/2003
12/25/2003US20030236251 Hepatitis virus viricides
12/25/2003US20030236216 For the treatment of diseases mediated by the Hepatitis C Virus
12/25/2003US20030235853 Solid phase synthesis; for drug screening
12/25/2003US20030235822 Computer software for mismatch discrimination based on thermodynamics
12/24/2003WO2003107144A2 Systems and methods for predicting oligonucleotide melting temperatures (tms)
12/24/2003WO2003106475A2 Process
12/24/2003WO2003106458A1 Alkynylpurine compounds and production methods thereof
12/24/2003WO2003055896A3 Anti-viral 7-deaza l-nucleosides
12/24/2003CN1463292A Method for identifying polymorphisms
12/24/2003CA2490466A1 Systems and methods for predicting oligonucleotide melting temperatures (tms)
12/24/2003CA2489468A1 Alkynylpurine compounds and production methods thereof
12/18/2003WO2003104250A1 New compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
12/18/2003WO2003087130A3 Process for manufacturing purified phosphorodiamidite
12/18/2003WO2003051306A3 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections
12/18/2003WO2003004510A1 Two-stage protective groups for the synthesis of biopolymers
12/18/2003US20030232980 Methods of producing phosphitylated compounds
12/18/2003US20030232979 Nucleic acid labeling compounds
12/18/2003US20030232783 Partial and full agonists of A1 adenosine receptors
12/17/2003EP1370673A1 Topoisomerase i selective cytotoxic sugar derivatives of indolopyrrolocarbazoles
12/17/2003EP1370569A1 Process for preparing n6-substituted aminopurine ribofuranose nucleosides
12/17/2003EP1370568A1 Chemical compounds
12/17/2003EP1370567A2 Method for the production of pentopyranosyl nucleosides
12/17/2003EP1370139A2 Inhibitors of adp-ribosyl transferases, cyclases, and hydrolases, and uses thereof
12/17/2003EP1283845B1 Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine
12/17/2003EP1102781B1 New cofactors for methyltransferases
12/16/2003US6664399 Linkage less susceptible to hydrolysis
12/16/2003US6664079 Sequencing nucleic acid; obtain nucleotide sequences, incubate in reaction mixture, apply to solid support, determine nucleotide sequences
12/16/2003US6664058 A nucleotide, e.g., 6-(beta-D-2-Deoxyribofuranosyl)-5-hydro-methyl-8H-pyrimido(4,5 -c)(1,2)pyridazin-7-one-5'-triphosphate, incorporated into a polynuceotide or an oligomucleotide; viricides; labels
12/16/2003CA2092038C Process for the preparation of nucleosides
12/11/2003WO2003101198A1 Improved inhibitors of adp-ribosyl transferases, cyclases, and hydrolases
12/11/2003WO2003053988A3 Avermectin b1 derivatives having an aminosulfonyloxy substituent in the 4''-position
12/11/2003WO2003020984A3 Terminal-phosphate-labeled nucleotides and methods of use
12/11/2003WO2002094273A3 Combination of an adenosine a2a-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways
12/11/2003WO2002087465A3 Compositions and methods of double-targeting virus infections and cancer cells
12/11/2003WO2002048165A8 Antiviral agents for treatment of flaviviridae infections
12/11/2003US20030229223 Method for purifying protected 2'-deoxycytidines and hydrated crystals thereof
12/11/2003US20030229220 Oligomer phosphoramidite compositions and processes for synthesizing the same
12/11/2003US20030229219 Preparation of phosphorothioate oligomers
12/11/2003US20030229115 Organ rejection disease; autoimmune disease; immunosuppressants
12/11/2003US20030229033 Inhibitors of ADP-ribosyl transferases, cyclases, and hydrolases
12/11/2003US20030228604 System for tracing animal products
12/11/2003US20030228576 Nucleotide sequence coding for a cleaving enzyme; can use in conjuction with substrate to produce toxins which impair abnormal cell growth; antitumor agents
12/10/2003EP1369424A1 Method for purifying protected 2'-deoxycytidines
12/10/2003EP1368366A1 Non-natural nucleotides and dinucleotides
12/10/2003EP1368365A2 C2,5'-disubstituted and n6,c2,5'-trisubstituted adenosine derivatives and their different uses
12/10/2003EP1368364A1 C2, 8-disubstituted adenosine derivatives and their different uses
12/10/2003EP1368040A2 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
12/10/2003EP1189916B1 N-pyrazole a 2a receptor agonists
12/10/2003EP1058687B1 Nucleosides
12/10/2003EP0651759B1 Novel 2'-o-alkyl nucleosides and phosphoramidites processes for the preparation and uses thereof
12/10/2003CN1130362C Nucleosides analogues, such as antivirals including inhititors of retroviral reverse transcriptase and DNA polymerase of heaptitis B virus (HBV)
12/09/2003US6660854 Processes for preparing β-D-ribofuranose derivatives
12/09/2003US6660723 Activating primate gamma delta lymphocytes
12/09/2003US6660721 Anti-HCV nucleoside derivatives
12/09/2003US6660234 Generation of preferential nucleotide sequences on preferential substrate; obtain substrate, expose to activator, remove terminal groups, recover biopolymer
12/09/2003CA2129986C Amphiphile nucleosidphosphatanaloga
12/09/2003CA2051217C Process for the chemical synthesis of oligonucleotides
12/04/2003WO2003100097A1 Fluorescence polarization detection of nucleic acids
12/04/2003WO2003099840A1 Oligonucleotides having modified nucleoside units
12/04/2003WO2003099342A1 Labeled adenosine for use in positron emission tomography
12/04/2003WO2003039523A3 OLIGONUCLEOTIDES MODIFIED WITH NOVEL α-L-RNA ANALOGUES
12/04/2003WO2003022859A3 Process for the synthesis of pyrazolopyrimidines
12/04/2003WO2003006625A3 Nucleotide compositions comprising photocleavable markers and methods of preparation thereof
12/04/2003WO2003004603A3 Methods of modulating pharmacokinetics of oligonucleotides
12/04/2003WO2002078747A8 Pregabalin lactose conjugates
12/04/2003US20030225284 Process for manufacturing purified phosphorodiamidite
12/04/2003US20030225279 Stavudine Polymorphic Form 1 process
12/04/2003US20030225262 Reagent and process for protecting active groups
12/04/2003US20030225205 Nucleoside analog libraries
12/04/2003US20030225029 Dosing regimen for gemcitabine HCV therapy
12/04/2003US20030225028 Beta-L-2'deoxy-nucleosides for the treatment of hepatitis B
12/04/2003US20030224377 Novel LNA compositions and uses thereof
12/04/2003US20030224359 Tmleveling methods
12/04/2003CA2486410A1 Fluorescence polarization detection of nucleic acids
12/03/2003EP1366056A4 Preparation of deoxynucleosides
12/03/2003EP1366056A2 Preparation of deoxynucleosides
12/03/2003EP1366055A2 Antiviral agents for treatment of flaviviridae infections
12/03/2003CN1460109A Improved specificity in treatment of diseases
12/02/2003US6656917 Compositions and methods for targeted enzymatic release of cell regulatory compounds
12/02/2003CA2246909C Method for chemical synthesis of oligonucleotides
11/2003
11/27/2003WO2003051901A3 Pseudonucleotide comprising an intercalator
11/27/2003WO2003048178A3 Nucleotide analogues and their use for nucleic acid sequencing
11/27/2003WO2002103008A3 Templated molecules and methods for using such molecules
11/27/2003WO2002068441A3 Avermectins substituted in the 4'-position having pesticidal properties
11/27/2003US20030220387 Nitrogen compounds such as 3,9-Difluoro-12,13-dihydro-13-((3,6 -anhydro)-beta-D- glucopyranosyl)-5H-indolo(2,3-a)pyrrolo(3,4 -c)carbazole-5,7(6H)-dione, used as topoisomerase inhibitors, antiproliferative or antitumor agents
11/27/2003US20030220290 E.g., beta-L-2'-deoxyadenosine
11/27/2003US20030219754 Apparatus for replication and identification of labeled nucleotide sequences
11/27/2003US20030219727 Prodrugs of phosphonate nucleotide analogues
11/26/2003EP1364959A1 Crystal of pyrimidine nucleoside derivative
11/26/2003EP1363928A1 Process for the preparation of (e)-5-(2-bromovinyl)-2'-deoxyuridine
11/26/2003EP1363927A2 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
11/26/2003EP1363926A1 Salts of avermectins substituted in the 4"-position and having pesticidal properties
11/26/2003EP1363644A2 Modulation of gsk-3beta activity and its different uses
11/26/2003EP1363581A2 Pyrrolo(2,3-d)pyrimidine nucleoside analogs
11/26/2003EP1258490B1 Process for preparing indolopyrrolocarbazole derivatives, intermediates thereof, and preparation process of the intermediates
11/26/2003EP0760375B1 Antitumor indolopyprolocarbazole derivative
11/25/2003USRE38332 Selected soluble esters of hydroxyl-containing indolocarbazoles
11/25/2003US6653462 Nucleotide compounds including a rigid linker
11/25/2003US6653342 13-substituted milbemycin derivatives, their preparation and their use against insects and other pests
11/25/2003US6653318 Varicella zoster and epstein barr viruses
1 ... 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 ... 201